ATF6 and Hyperglycemia: In the present study, we demonstrated that the hyperglycemia-triggered ATF6–CHOP axis aggravated IR-induced liver injury via inactivation of β-catenin, which in turn promoted TLR4-driven inflammatory responses, while simultaneously repressing Akt signaling molecules in the ischemic liver.